Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
Callodine Capital Management LP Purchases 109,240 Shares of Sanofi $SNY
04:52am, Sunday, 07'th Dec 2025
Callodine Capital Management LP grew its holdings in Sanofi (NASDAQ: SNY) by 26.9% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund owned 515
Market Today: Netflix-WBD Deal, X Fined, Meta's News Pacts
05:36pm, Friday, 05'th Dec 2025
Guru Stock PicksJana Partners has made the following transactions:Reduce in MRCY by 16.66%Add in THS by 0.13%Stock News Netflix wins WBD studio deal: Netflix (N
Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
01:35pm, Friday, 05'th Dec 2025
Vaccine makers expressed concern on Friday's decision by a U.S. advisory panel to scrap its long-standing recommendation that all infants receive a hepatitis B vaccine at birth, a shift that public he
3 Large Drug Stocks to Watch as the Industry Shows Some Recovery
10:31am, Thursday, 04'th Dec 2025
In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.
Press Release: Sanofi completes acquisition of Vicebio
05:00am, Thursday, 04'th Dec 2025
Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”).
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes
03:00am, Thursday, 04'th Dec 2025
LONDON--(BUSINESS WIRE)-- #AI--LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic
Sanofi (SAN:CA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
07:23pm, Wednesday, 03'rd Dec 2025
Sanofi (SAN:CA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
3 Potential Mid-Cap Biotech Buyout Targets In 2026
06:22pm, Wednesday, 03'rd Dec 2025
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks
Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript
07:03am, Wednesday, 03'rd Dec 2025
Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript
Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation
11:05am, Wednesday, 26'th Nov 2025
Sanofi stock dropped Wednesday after French authorities raided the drugmaker's Paris headquarters as part of a tax fraud investigation.
Sanofi (NASDAQ:SNY) Given Consensus Rating of “Buy” by Analysts
04:24am, Wednesday, 26'th Nov 2025
Shares of Sanofi (NASDAQ: SNY - Get Free Report) have received an average recommendation of "Buy" from the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. Two researc
Sanofi $SNY Shares Bought by American Century Companies Inc.
03:05am, Wednesday, 26'th Nov 2025
American Century Companies Inc. lifted its stake in shares of Sanofi (NASDAQ: SNY) by 29.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commiss
Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe
01:30pm, Tuesday, 25'th Nov 2025
Sanofi SA's (NASDAQ: SNY) Paris headquarters received an unannounced visit on Tuesday as tax investigators, accompanied by prosecutors and specialist aides, searched the site amid a widening financial
SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
11:46am, Tuesday, 25'th Nov 2025
Sanofi/Regeneron's Dupixent wins EU nod for chronic spontaneous urticaria, marking its seventh approved indication across inflammatory diseases in the EU.
Aviso Financial Inc. Grows Stock Holdings in Sanofi $SNY
03:32am, Tuesday, 25'th Nov 2025
Aviso Financial Inc. boosted its holdings in shares of Sanofi (NASDAQ: SNY) by 4.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Th
